Activists and 5% owners

Item 4, purpose of the transaction: The response to Item 3 of this Schedule 13D is incorporated herein by reference. Effective upon Closing, the Issuer's board of directors (the "Board") appointed Mr. Samra as Chief Executive Officer of the Issuer. The Reporting Persons acquired beneficial ownership of the securities reported herein in connection with the Merger, and Mr. Samra's role as Chief Executive Officer and a co-founder of Host Infrastructure Holdings LLC (the "Sponsor"), for investment purposes. In his capacity as Chief Executive Officer of the Issuer, Mr. Samra may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of…

Item 4, purpose of the transaction: The response to Item 3 of this Schedule 13D is incorporated herein by reference. The Reporting Persons acquired beneficial ownership of the securities reported herein in connection with the Merger, and Mr. Thomas's role as a co-founder of Host Infrastructure Holdings LLC (the "Sponsor"), for investment purposes. The Reporting Persons expect to review from time to time their investment in the Issuer and may, depending on the market and other conditions, and subject to any agreements between Mr. Thomas and the Issuer, including as described herein, and applicable legal requirements, (i) purchase or acquire additional shares of Class A Common Stock, options, or related derivatives in the open…

Item 4, purpose of the transaction: The Reporting Persons acquired the Class B Shares for investment purposes and to obtain voting control of the Issuer. On September 16, 2026, pursuant to the Purchase Agreement, Lioness purchased from the Seller all 500,000 Class B Shares, constituting all issued and outstanding Class B Shares, for aggregate consideration of US$500.00. The Class B Shares were transferred to Lioness on September 22, 2026. Voting rights and class terms. Under the Issuer's memorandum and articles of association, the Class A Shares and Class B Shares vote together as one class on resolutions submitted to shareholders. Each Class A Share is entitled to one vote, and each Class B Share is entitled to 100 votes. T…

Item 4, purpose of the transaction: The Reporting Persons originally purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. Seidman h…

Item 4, purpose of the transaction: The Reporting Person acquired beneficial ownership of the Ordinary Shares reported herein in connection with the closing of the Merger on August 26, 2026, as described in Item 3 above. In addition, the Reporting Person exercises control over 20,000 Ordinary Shares held directly by Apollo Technology Capital Corporation (formerly known as Nobul AI Corp.) and/or its affiliates, which were acquired prior to the Merger. The Reporting Person serves as Chairman of the Board of Directors of the Issuer. The Reporting Person intends to review his investment in the Issuer on a continuing basis and may from time to time acquire additional Ordinary Shares, or retain or sell all or a portion of the Ordin…

Item 4, purpose of the transaction: The information set forth in Item 3 of this Schedule 13D is incorporated by reference into this Item 4. TPC acquired the reported securities for investment purposes.

Item 4, purpose of the transaction: The information set forth in Item 3 of this Schedule is incorporated herein by reference. WJRJJ purchased shares of the Company's common stock pursuant to a Securities Purchase Agreement ("Securities Purchase Agreement"), dated as of September 11, 2026, by and among WJRJJ, the Company, and Robert A. Frist (the "Selling Shareholder"), under which (i) the Company agreed to issue to WJRJJ 1,355,932 shares of Common Stock, for an aggregate cash purchase price of approximately $40.0 million, or a purchase price of $29.50 per share, and (ii) the Selling Shareholder agreed to sell to WJRJJ 144,068 shares of Common Stock for an aggregate cash purchase price of approximately $4.25 million, or a purc…

Item 4, purpose of the transaction: Takeover Time 2026 LLC (the "Reporting Person") beneficially owns 1,846,000 shares, representing approximately 62.45% of the Issuer's Class A common stock based on the Issuer's most recently reported outstanding share count. In light of this substantial ownership position, the Reporting Person, for now, intends to seek a seat on the Issuer's Board of Directors for its sole owner and managing member, Natasha Ovsepyan. The Reporting Person requests that the Board promptly contact Ms. Ovsepyan to initiate direct discussions regarding board representation and the appropriate steps to facilitate her participation in the Issuer's governance. Direct correspondence should be addressed to Natasha Ovs…

Item 4, purpose of the transaction: The securities were acquired as compensation for services, through conversion or restructuring of amounts owed for services previously rendered, and for investment purposes. Ms. White has provided finance and accounting consulting services to the Issuer through 2752128 Ontario Ltd. The Reporting Persons may from time to time review their investment in the Issuer and, depending on market conditions, the Issuer's business and prospects, availability of funds, legal and regulatory considerations and other factors deemed relevant, may acquire additional securities, dispose of securities, convert outstanding convertible securities, exercise outstanding options, or otherwise change their investme…

Item 4, purpose of the transaction: The information set forth in Item 3 of this Schedule is incorporated herein by reference. The Reporting Person acquired their shares of Common Stock, Pre-Funded Warrants and Common Warrants as an investment in the ordinary course of business. At the Milestone Closing, which will be triggered by the Issuer's submission of a registrational Phase 3 clinical trial protocol for PDS0301 designed in collaboration with Nant Capital to the U.S. Food & Drug Administration (the "Milestone Event"), Nant Capital, along with certain other PIPE Investors, will be obligated to purchase and the Issuer will be obligated to issue to Nant Capital shares of Comon Stock or Pre-Funded Warrants in lieu thereof for…

Item 4, purpose of the transaction: INVESTMENT

Item 4, purpose of the transaction: The securities were acquired as compensation for services, through conversion or restructuring of amounts owed for services previously rendered, and for investment purposes. Mr. O'Connor served as an officer and director of the Issuer at the time of the January 2, 2025 acquisition and subsequently ceased serving as an officer and director in September 2026. The Reporting Persons may from time to time review their investment in the Issuer and, depending on market conditions, the Issuer's business and prospects, availability of funds, legal and regulatory considerations and other factors deemed relevant, may acquire additional securities, dispose of securities, convert outstanding convertible…

Item 4, purpose of the transaction: On March 17, 2026, in connection with the Issuer's restructuring of its debt obligations (the "Restructuring Transactions"), the Issuer and certain of its subsidiaries entered into a restructuring support agreement (the "RSA"). On September 11, 2026, pursuant to the RSA, certain debt instruments of the Issuer held by affiliates of the Reporting Persons with an aggregate principal amount of $564,468,399.13 were terminated and exchanged for an aggregate of 1,318,372 shares of Class A Common Stock and 305,225 shares of Preferred Stock. Each Reporting Person expects to continuously review such person's investment in the Issuer and, depending on various factors including but not limited to, the …

Item 4, purpose of the transaction: On March 11, 2026, PRIME OCEAN HOLDINGS LIMITED (the "Transferor") and JMD CORPORATE SERVICES LIMITED (the "Transferee") entered into a share transfer agreement, pursuant to which PRIME OCEAN HOLDINGS LIMITED agreed to transfer certain shares held by it to JMD CORPORATE SERVICES LIMITED. Under the terms of the share transfer agreement, Transferor is the registered proprietor of 18.000.000 ordinary shares (certificate no. C1353) with a par value of US$0.004 each of the TROOPS, INC. In addition, pursuant to the terms of the share transfer agreement, the ordinary shares shall be transferred for consideration of US$16,680,000. The Reporting Person is filing this Schedule 13D to report its purp…

Item 4, purpose of the transaction: On September 15, 2026, the Issuer and the reporting person entered into a securities purchase agreement relating to the issuance and sale of 298,508 shares of the Issuer's common stock and accompanying warrants to purchase up to 298,508 shares of common stock in a private placement. The transaction closed on September 15, 2026. The warrants are exercisable at any time, have an exercise price of $1.55 per share, and expire on the five-year anniversary of the date of issuance. The warrants also contain standard anti-dilution adjustments to the exercise price including for stock splits, stock dividends, rights offerings and pro rata distributions. The Issuer issued the shares and warrants to th…

Item 4, purpose of the transaction: The Reporting Persons acquired the shares for investment purposes, and have the right to an additional 65,000 shares as described above. The Reporting Persons may, from time to time, acquire additional shares of Common Stock in the open market, in privately negotiated transactions, or otherwise, or may dispose of all or a portion of the shares of Common Stock held by them, subject to applicable securities law restrictions, including any lock-up or registration requirements. The Reporting Persons may also engage in discussions with the Issuer's management, board of directors, or other stockholders regarding the Issuer's business, management, operations, strategy, or governance. Any such acti…

Item 4, purpose of the transaction: On September 16, 2026, Gang Yu, Junling Liu, Sunny Bay Global Limited and Huadeng Tech BioArray Ventures Ltd (collectively, the Consortium) entered into a consortium agreement (the Consortium Agreement), pursuant to which the Consortium will cooperate in good faith in connection with an acquisition transaction (Proposed Transaction) with respect to the Issuer as contemplated by the Proposal (as defined below). The Consortium Agreement provides, among others, for (i) cooperation in negotiation with the Issuer with respect to the Proposed Transaction; (ii) cooperation in engaging advisors; and (iii) cooperation in entry into definitive documentation with respect to the Proposed Transaction. Du…

Item 4, purpose of the transaction: The Reporting Persons purchased the Shares disclosed in this Statement based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advi…

Item 4, purpose of the transaction: The information reported in Item 3 of this Schedule 13D is incorporated by reference into this Item 4. An aggregate of 2,939,976 shares of Class A common stock described in Item 3 of this Schedule 13D that were purchased by Mr. Rogers pursuant to the Subscription Agreement and the exercise of certain stock options by Mr. Rogers in March 2021 were acquired for investment purposes. All other securities reported herein were acquired as compensation for Mr.Rogers' service as a director of the Issuer. Mr. Rogers has been a director of the Issuer since September 13, 2021 and will continue to be involved in supervision of the Issuer in such role. Effective September 10, 2026, Mr. Rogers was appoin…

Item 4, purpose of the transaction: The Reporting Persons acquired and hold the securities reported in this statement as consideration for the Block 40 transaction described in Item 3 and for investment. Neither Mr. Abele nor Mr. Jago is a director or officer of the Issuer. The July 11, 2025 purchase documents contemplated certain Block 40-level employment and oversight roles for Messrs. Abele and Jago. Those roles, if still in effect, relate to the real-estate subsidiary and not to control of the Issuer. The 1,001 shares held of record by John Clive David Jago were not acquired in the Block 40 transaction and are held for personal investment. They do not reflect a plan or proposal by the Reporting Persons with respect to th…

Item 4, purpose of the transaction: The Reporting Persons acquired and hold the securities reported in this statement for investment and in connection with Mr. Steward's role as Chairman of the Board and a director of the Issuer and the Reporting Persons' historical financing of the Issuer. Mr. Steward serves as Chairman and director and, in that capacity, participates in ordinary Board decisions concerning the Issuer's business, capitalization, compensation, listing, and governance. Forfront Capital, LLC is party to a Voting Agreement dated August 25, 2025 under which it votes 10,000,000 shares of Series B Preferred Stock (50 votes per share) at the direction of a majority of the Issuer's founders (Glen Steward, Vincent Napo…

Item 4, purpose of the transaction: The Reporting Persons acquired and hold the securities reported in this statement for investment and in connection with Mr. Napolitano's historical role as founder, former Chief Executive Officer and Chairperson, and current Director Emeritus. Mr. Napolitano is not a voting director. He does not vote on Board actions. Mr. Napolitano is one of the Issuer's founders named in the Voting Agreement dated August 25, 2025, among the Issuer and Forfront Capital, LLC. Under that agreement, Forfront votes 10,000,000 shares of Series B Preferred Stock (50 votes per share) at the direction of a majority of Vincent Napolitano, Vincent Napolitano, and Glen Steward. The Issuer's President holds an irrevo…

Item 4, purpose of the transaction: The Reporting Persons acquired and hold the securities reported in this statement for investment and in connection with Mr. Quin's role as founder, Chief Executive Officer, Principal Executive Officer, and director of the Issuer. Mr. Quin participates, as CEO and director, in ordinary Board and management decisions concerning the Issuer's business, capitalization, compensation, listing, and governance. Mr. Quin is one of the Issuer's founders named in the Voting Agreement dated August 25, 2025, among the Issuer and Forfront Capital, LLC. Under that agreement, Forfront votes 10,000,000 shares of Series B Preferred Stock (50 votes per share) at the direction of a majority of Vincent Napolita…

Item 4, purpose of the transaction: The Reporting Person acquired shares of Dynatrace Inc as part of its investment strategy, which includes considering the clarity and robustness of the issuer's long-term strategy; the functioning and calibre of governance structures and effective leadership; the financial strength and performance of issuers and the fair valuation of underlying securities; and financially-material sustainability risks & opportunities. The Reporting Person is therefore actively engaging with the Issuer to discuss and promote initiatives that align with these business practices. This engagement is part of the Reporting Person's broader strategy to support companies in enhancing their approach, thereby potentia…

Item 4, purpose of the transaction: The responses to Item 6 are incorporated by reference into this Item 4. On September 10, 2026 (the "Closing Date"), Issuer issued and sold to MIG the following securities pursuant to the Subscription Agreement, dated as of July 19, 2026 (the "Subscription Agreement"), between Issuer and MIG, for an aggregate purchase price of $15,000,000: * 2,923,976 shares of Class A Common Stock at a purchase price of $1.71 per share; * a senior secured convertible promissory note in the initial principal amount of $10,000,000 (the "MIG Convertible Note"), which, subject to obtaining the regulatory approvals required under the Subscription Agreement (the "Regulatory Approvals"), is initially c…